no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies
|
Massari, Francesco |
|
2018 |
68 |
C |
p. 80-85 |
article |
2 |
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|
Gerratana, L. |
|
2018 |
68 |
C |
p. 102-110 |
article |
3 |
Assessment of the risk of antiangiogenic agents before and after surgery
|
Bailey, Christina E. |
|
2018 |
68 |
C |
p. 38-46 |
article |
4 |
Borderline resectable pancreatic cancer. Challenges and controversies
|
Sabater, Luis |
|
2018 |
68 |
C |
p. 124-135 |
article |
5 |
Burnout in oncologists is a serious issue: What can we do about it?
|
Murali, Krithika |
|
2018 |
68 |
C |
p. 55-61 |
article |
6 |
Cardiotoxicity associated with radiotherapy in breast cancer: A question-based review with current literatures
|
Zhu, Qian |
|
2018 |
68 |
C |
p. 9-15 |
article |
7 |
Clinical development of HER3-targeting monoclonal antibodies: Perils and progress
|
Jacob, Wolfgang |
|
2018 |
68 |
C |
p. 111-123 |
article |
8 |
Does pelvic radiation increase rectal cancer incidence? – A systematic review and meta-analysis
|
Rombouts, A.J.M. |
|
2018 |
68 |
C |
p. 136-144 |
article |
9 |
Editorial Board
|
|
|
2018 |
68 |
C |
p. ii |
article |
10 |
Emerging therapeutic modalities of PARP inhibitors in breast cancer
|
Wang, Xin |
|
2018 |
68 |
C |
p. 62-68 |
article |
11 |
Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned
|
Arndt, Carola A.S. |
|
2018 |
68 |
C |
p. 94-101 |
article |
12 |
Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?
|
Lefranc, Florence |
|
2018 |
68 |
C |
p. 145-154 |
article |
13 |
Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
|
El Rassy, Elie |
|
2018 |
68 |
C |
p. 69-79 |
article |
14 |
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
|
Raoul, Jean-Luc |
|
2018 |
68 |
C |
p. 16-24 |
article |
15 |
Targeted alpha therapy using Radium-223: From physics to biological effects
|
Marques, I.A. |
|
2018 |
68 |
C |
p. 47-54 |
article |
16 |
The relationship between anticipated response and subsequent experience of cancer treatment-related side effects: A meta-analysis comparing effects before and after treatment exposure
|
Fletcher, Chloe |
|
2018 |
68 |
C |
p. 86-93 |
article |
17 |
The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer
|
Saad, Fred |
|
2018 |
68 |
C |
p. 25-37 |
article |
18 |
Toward innovative combinational immunotherapy: A systems biology perspective
|
Li, Xue-Tao |
|
2018 |
68 |
C |
p. 1-8 |
article |